86 Diabetes
Agrawal, L., Azad, N., Bahn, G. D., Ge, L., Reaven, P. D., Hayward, R. A., … for the VADT Study Group. (2018). Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs diabetes trial (VADT). Diabetologia, 61(2), 295–299. https://doi.org/10.1007/s00125-017-4473-2
Anderson, T. S., Lee, S., Jing, B., Fung, K., Ngo, S., Silvestrini, M., & Steinman, M. A. (2020). Prevalence of diabetes medication intensifications in older adults discharged from US Veterans Health Administration hospitals. JAMA Network Open, 3(3), e201511. https://doi.org/10.1001/jamanetworkopen.2020.1511
Arney, J. B., Odom, E., Brown, C., Jones, L., Kamdar, N., Kiefer, L., Hundt, N., Gordon, H. S., Naik, A. D., & Woodard, L. D. (2020). The value of peer support for self-management of diabetes among veterans in the empowering patients in chronic care intervention. Diabetic Medicine, 37(5), 805–813. https://doi.org/10.1111/dme.14220
Avramovic, S., Alemi, F., Kanchi, R., Lopez, P. M., Hayes, R. B., Thorpe, L. E., & Schwartz, M. D. (2020). US Veterans Administration Diabetes Risk (VADR) national cohort: Cohort profile. BMJ Open, 10(12), e039489. https://doi.org/10.1136/bmjopen-2020-039489
Bailin, S. S., McGinnis, K. A., McDonnell, W. J., So-Armah, K., Wellons, M., Tracy, R. P., Doyle, M. F., Mallal, S., Justice, A. C., Freiberg, M. S., Landay, A. L., Wanjalla, C., & Koethe, J. R. (2020). T lymphocyte subsets associated with prevalent diabetes in veterans with and without human immunodeficiency virus. The Journal of Infectious Diseases, 222(2), 252–262. https://doi.org/10.1093/infdis/jiaa069
Bessesen, M. T., Doros, G., Henrie, A. M., Harrington, K. M., Hermos, J. A., Bonomo, R. A., Ferguson, R. E., Huang, G. D., & Brown, S. T. (2020). A multicenter randomized placebo controlled trial of rifampin to reduce pedal amputations for osteomyelitis in veterans with diabetes (VA INTREPID). BMC Infectious Diseases, 20(1), 23. https://doi.org/10.1186/s12879-019-4751-3
Butt, A. A., Yan, P., Aslam, S., Shaikh, O. S., & Abou-Samra, A.-B. (2020). Hepatitis C virus (HCV) treatment with directly acting agents reduces the risk of incident diabetes: Results from electronically retrieved cohort of HCV infected veterans (ERCHIVES). Clinical Infectious Diseases, 70(6), 1153–1160. https://doi.org/10.1093/cid/ciz304
Davis, S. N., Duckworth, W., Emanuele, N., Hayward, R. A., Wiitala, W. L., Thottapurathu, L., Reda, D. J., & Reaven, P. D. (2019). Effects of severe hypoglycemia on cardiovascular outcomes and death in the Veterans Affairs diabetes trial. Diabetes Care, 42(1), 157–163. https://doi.org/10.2337/dc18-1144
DiNardo, M. M., Phares, A. D., Jones, H. E., Beyer, N. M., Suss, S. J., McInnes, S., & Rodriguez, K. L. (2020). Veterans’ experiences with diabetes: A qualitative analysis. The Diabetes Educator, 46(6), 607–616. https://doi.org/10.1177/0145721720965498
El-Gabalawy, R., Blaney, C., Tsai, J., Sumner, J. A., & Pietrzak, R. H. (2018). Physical health conditions associated with full and subthreshold PTSD in U.S. military veterans: Results from the National Health and Resilience in Veterans study. Journal of Affective Disorders, 227, 849–853. https://doi.org/10.1016/j.jad.2017.11.058
Fields, B., Makaroun, L., Rodriguez, K. L., Robinson, C., Forman, J., & Rosland, A.-M. (2020). Caregiver role development in chronic disease: A qualitative study of informal caregiving for veterans with diabetes. Chronic Illness, 1742395320949633. https://doi.org/10.1177/1742395320949633
Gatwood, J., Chisholm-Burns, M., Davis, R., Thomas, F., Potukuchi, P., Hung, A., & Kovesdy, C. P. (2018). Evidence of chronic kidney disease in veterans with incident diabetes mellitus. PLOS ONE, 13(2), e0192712. https://doi.org/10.1371/journal.pone.0192712
Grabarczyk, T. R., & Wissman, N. K. (2020). Weight outcomes with Empagliflozin as compared with Liraglutide in veterans with type 2 diabetes mellitus. Annals of Pharmacotherapy, 54(10), 981–987. https://doi.org/10.1177/1060028020915791
Gray, K. E., Hoerster, K. D., Reiber, G. E., Bastian, L. A., & Nelson, K. M. (2019). Multiple domains of social support are associated with diabetes self-management among veterans. Chronic Illness, 15(4), 264–275. https://doi.org/10.1177/1742395318763489
Helmer, D. A., Rowneki, M., Xue Feng, Chin-lin Tseng, Rose, D., Soroka, O., … Sambamoorthi, U. (2018). State-level variability in veteran reliance on Veterans Health Administration and potentially preventable hospitalizations: A geospatial analysis. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 55, 1–11. https://doi.org/10.1177/0046958018756216
Hunt, K. J., Davis, M., Pearce, J., Bian, J., Guagliardo, M. F., Moy, E., Axon, R. N., & Neelon, B. (2020). Geographic and racial/ethnic variation in glycemic control and treatment in a national sample of veterans with diabetes. Diabetes Care, 43(10), 2460–2468. https://doi.org/10.2337/dc20-0514
Karran, M., Guerrero-Berroa, E., Schmeidler, J., Lee, P. G., Alexander, N., Nabozny, M., West, R. K., Beeri, M. S., Sano, M., & Silverman, J. M. (2019). Recruitment of older veterans with diabetes risk for Alzheimer’s Disease for a randomized clinical trial of computerized cognitive training. Journal of Alzheimer’s Disease, 69(2), 401–411. https://doi.org/10.3233/JAD-180952
Kim, Y. A., Lee, Y., & Seo, J. H. (2020). Renal complication and glycemic control in Korean veterans with type 2 diabetes: A 10-year retrospective cohort study. Journal of Diabetes Research, 2020, e9806790. https://doi.org/10.1155/2020/9806790
Lee, A. A., Heisler, M., Trivedi, R., Leukel, P., Mor, M. K., & Rosland, A.-M. (2020). Autonomy support from informal health supporters: Links with self-care activities, healthcare engagement, metabolic outcomes, and cardiac risk among veterans with type 2 diabetes. Journal of Behavioral Medicine. https://doi.org/10.1007/s10865-020-00196-5
Lee, S., Bae-Shaaw, Y. H., Gogineni, H., Worley, M. M., & Law, A. V. (2020). Triple strength utility of the modified drug adherence work-up (M-DRAW) tool in a Veterans Affairs outpatient diabetes clinic. Research in Social and Administrative Pharmacy, 16(7), 914–920. https://doi.org/10.1016/j.sapharm.2019.09.063
Leung, L. B., Steers, W. N., Hoggatt, K. J., & Washington, D. L. (2020). Explaining racial-ethnic differences in hypertension and diabetes control among veterans before and after patient-centered medical home implementation. Plos One, 15(10), e0240306. https://doi.org/10.1371/journal.pone.0240306
Lipska, K. J., & Laiteerapong, N. (2019). Lack of glycemic legacy effects in the Veterans Affairs Diabetes Trial. The New England Journal of Medicine, 380(23), 2266–2267. https://doi.org/10.1056/NEJMe1905495
Long, J. A., Ganetsky, V. S., Canamucio, A., Dicks, T. N., Heisler, M., & Marcus, S. C. (2020). Effect of peer mentors in diabetes self-management vs usual care on outcomes in US veterans with type 2 diabetes: A randomized clinical trial. JAMA Network Open, 3(9), e2016369–e2016369. https://doi.org/10.1001/jamanetworkopen.2020.16369
Mathur, R., Hui, Q., Huang, Y., Gwinn, M., So-Armah, K., Freiberg, M. S., Justice, A. C., Xu, K., Marconi, V. C., & Sun, Y. V. (2019). DNA methylation markers of type 2 diabetes mellitus among male veterans with or without human immunodeficiency virus infection. The Journal of Infectious Diseases, 219(12), 1959–1962. https://doi.org/10.1093/infdis/jiz023
McDaniel, J. T., Davis, J., Anton, P. M., Godfrey, K., Albright, D., Thomas, K. H., Fletcher, K. L., & Nuhu, K. (2019). Physical activity and mental distress among veteran cancer survivors with heart disease and diabetes. Journal of Military, Veteran and Family Health, 5(2), 67–74. https://doi.org/10.3138/jmvfh.2018-0010
Myers, J., de Souza e Silva, C. G., Doom, R., Fonda, H., Chan, K., Kamil-Rosenberg, S., & Kokkinos, P. (2019). Cardiorespiratory fitness and health care costs in diabetes: The veterans exercise testing study. The American Journal of Medicine, 132(9), 1084–1090. https://doi.org/10.1016/j.amjmed.2019.04.006
Navaneethan, S. D., Akeroyd, J. M., Ramsey, D., Ahmed, S. T., Mishra, S. R., Petersen, L. A., … Virani, S. S. (2018). Facility-level variations in kidney disease care among veterans with diabetes and CKD. Clinical Journal of the American Society of Nephrology, 13(12), 1842–1850. https://doi.org/10.2215/CJN.03830318
Niznik, J. D., Hunnicutt, J. N., Zhao, X., Mor, M. K., Sileanu, F., Aspinall, S. L., Springer, S. P., Ersek, M. J., Gellad, W. F., Schleiden, L. J., Hanlon, J. T., Thorpe, J. M., & Thorpe, C. T. (2020). Deintensification of diabetes medications among veterans at the end of life in VA nursing homes. Journal of the American Geriatrics Society, 68(4), 736–745. https://doi.org/10.1111/jgs.16360
Powell, W. R., Christiansen, C. L., & Miller, D. R. (2019). Long-term comparative safety analysis of the risks associated with adding or switching to a sulfonylurea as second-line Type 2 diabetes mellitus treatment in a US veteran population. Diabetic Medicine, 36(11), 1384–1390. https://doi.org/10.1111/dme.13839
Presley, C. A., Min, J. Y., Chipman, J., Greevy, R. A., Grijalva, C. G., Griffin, M. R., & Roumie, C. L. (2018). Validation of an algorithm to identify heart failure hospitalisations in patients with diabetes within the Veterans Health Administration. BMJ Open, 8(3), e020455. https://doi.org/10.1136/bmjopen-2017-020455
Raghavan, S., Ho, Y.-L., Vassy, J. L., Posner, D., Honerlaw, Costa, L., Phillips, L. S., Gagnon, D. R., Wilson, P. W. F., & Cho, K. (2020). Optimizing atherosclerotic cardiovascular disease risk estimation for veterans with diabetes mellitus. Circulation: Cardiovascular Quality and Outcomes, 13(9), e006528. https://doi.org/10.1161/CIRCOUTCOMES.120.006528
Schmidt, K., Caudill, J.-A., & Hamilton, T. (2019). Impact of clinical pharmacy specialists on glycemic control in veterans with type 2 diabetes. American Journal of Health-System Pharmacy, 76(S1), S9–S14. https://doi.org/10.1093/ajhp/zxy015
Serra, M. C., Kancherla, V., Khakharia, A., Allen, L. L., Phillips, L. S., Rhee, M. K., Wilson, P. W. F., & Vaughan, C. P. (2020). Long-term Metformin treatment and risk of peripheral neuropathy in older veterans. Diabetes Research and Clinical Practice, 170, 108486. https://doi.org/10.1016/j.diabres.2020.108486
Toriola, A. T., Luo, S., Thomas, T. S., Drake, B. F., Chang, S.-H., Sanfilippo, K. M., & Carson, K. R. (2020). Metformin use and pancreatic cancer survival among non-Hispanic white and African American U.S. veterans with diabetes mellitus. Cancer Epidemiology and Prevention Biomarkers, 29(1), 169–175. https://doi.org/10.1158/1055-9965.EPI-19-0781
Wakefield, B. J., & Vaughan-Sarrazin, M. (2018). Strain and satisfaction in caregivers of veterans with type 2 diabetes. The Diabetes Educator, 44(5), 435–443. https://doi.org/10.1177/0145721718790940
Wassell, K., Sullivan, J., Jett, B. P., & Zuber, J. (2018). Comparison of clinical pharmacy specialists and primary care physicians in treatment of type 2 diabetes mellitus in rural Veterans Affairs facilities. American Journal of Health-System Pharmacy, 75(5), S6–S12. https://doi.org/10.2146/ajhp160905
Weeda, E. R., Bishu, K. G., Ward, R., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020). Joint effect of race/ethnicity or location of residence and sex on low density lipoprotein-cholesterol among veterans with type 2 diabetes: A 10-year retrospective cohort study. BMC Cardiovascular Disorders, 20(1), 449. https://doi.org/10.1186/s12872-020-01730-8
Weeda, E. R., Bishu, K. G., Ward, R. C., Brown, E. A., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020). Impact of race and location of residence on statin treatment among veterans with type 2 diabetes mellitus. The American Journal of Cardiology, 125(10), 1492–1499. https://doi.org/10.1016/j.amjcard.2020.02.027
Wischik, D. L., Magny-Normilus, C., & Whittemore, R. (2019). Risk factors of obesity in veterans of recent conflicts: Need for diabetes prevention. Current Diabetes Reports, 19(9), 70. https://doi.org/10.1007/s11892-019-1191-9
Zhou, J. J., Koska, J., Bahn, G., & Reaven, P. (2019). Glycaemic variation is a predictor of all-cause mortality in the Veteran Affairs Diabetes Trial. Diabetes and Vascular Disease Research, 16(2), 178–185. https://doi.org/10.1177/1479164119827598
Zhou, J. J., Schwenke, D. C., Bahn, G., & Reaven, P. (2018). Glycemic variation and cardiovascular risk in the Veterans Affairs diabetes trial. Diabetes Care, 41(10), 2187–2194. https://doi.org/10.2337/dc18-0548